With two molecules in mid-stage trials, the pharma giant is taking another swing at the difficult disease with a greater ...

Testicular cancer, primarily affecting men aged 15-35, is witnessing advancements that significantly impact diagnosis and treatment outcomes. As the most common cancer in young men, early detection, ...

Latham leaders said they had their eyes on recruiting David Marriott for “several years,” particularly after working ...

In an en banc petition filed this month before the U.S. Court of Appeals for the Ninth Circuit, Takeda Pharmaceutical and Eli ...